Home Your basket
• Surgical management of pa...
   Price 10.50 €
• Mucoepidermoid carcinomas...
   Price 10.50 €
• The subjective visual ver...
   Price 10.50 €
• Voice prostheses: long-te...
   Price 10.50 €
• Esthesioneuroblastoma in ...
   Price 8.00 €
• Bilateral latero-pontine ...
   Price 5.50 €
• Oropharyngeal reconstruct...
   Price 10.50 €
• Treatments of hereditary ...
   Price 10.50 €
• Technique of upper blepha...
   Price 10.50 €
• Similarities between reti...
   Price 14.00 €
• Carotid body paragangliom...
   Price 8.50 €
• Mycobacterial cervical ly...
   Price 10.50 €
• Temporary loss of visual ...
   Price 8.50 €
• Can homograft ossicles st...
   Price 5.50 €
• Local anesthesia for coch...
   Price 8.50 €
• Vibrant Soundbridge for h...
   Price 10.50 €
• Cholesterol granuloma of ...
   Price 8.50 €
• Unusual location of pleom...
   Price 12.50 €
• Sarcoidosis of the thyroi...
   Price 12.50 €
• The Voice Handicap Index:...
   Price 10.50 €
• Evaluation of the handica...
   Price 10.50 €
• Tuberculosis of the laryn...
   Price 5.50 €
• IPSEN Foundation meeting:...
   Price 5.50 €
• Acute mesenteric ischemia...
   Price 5.50 €
• Life after total laryngec...
   Price 8.50 €
• Clinical implementation o...
   Price 5.50 €
• Chronic laryngitis...
   Price 8.50 €
• Role and importance of pH...
   Price 12.00 €
• Postural study on healthy...
   Price 10.50 €
• An original case of laryn...
   Price 8.50 €
• Cervical surgical emphyse...
   Price 5.50 €
• Prevalence of and risk fa...
   Price 10.50 €
• Non-traumatic nasal septa...
   Price 8.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Aspects of ageing on prof...
   Price 12.00 €
• Cholesteatoma by osteoma ...
   Price 8.50 €
• A retrospective study of ...
   Price 10.50 €

Total Order 341.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Download
o Issue N# 1 - 1999 o

CERVICO-FACIAL CARCINOLOGY

Elements of epidemiology and initiation of carcinogenesis in carcinomas of the upper aerodigestive tract. Future therapeutic consequence ?


Authors : G. Dolivet, P. Colosetti, J. L. Merlin, Cl. Depardieu, M. Lapeyre, E. Wattel, J. Sarini, J. Ton Van, L. Geoffrois, Ph. Lagarde (Vandoeuvre les Nancy)

Ref. : Rev Laryngol Otol Rhinol 1999;120,1:5-12.

Article published in french



Summary : The study of epidemiology and of the carcinogenesis in epidermoid carcinomas of the upper aerodigestive tract shows that their occurrence is not random. Tobacco abuse plays a major role, especially because of benzopyrene, mutagen of the P53 gene, however it is associated with many other potentiating factors : alcohol, metals, hydrocarbures, virus, food, climate, genetic fragility that create genetic lesions at the origin of carcinogenesis. The latter occurs as "field cancerization" with multiple alterations of the mucosa and general attack of the control systems of the differentiation, growth and cell apoptosis which usually protect the cell against the phenomena of carcinogenesis. The P53 protein gene, retinoid receptors as well as the system of detoxifying glutathion S transferase are modified at the very early stage of these diseases, these abnormalities can be logically related to epidemiological data. These date lead us therefore to imagine complementary specific reverting therapies of induced genetic abnormalities, through the reexpression of non mutated gene encoding P53 protein and the use of retinoid. These various modalities are reported hereafter.


|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE